SB 216641, with the CAS number 170230-39-4, is a chemical compound that has been studied primarily for its potential applications in pharmacology, particularly as a selective antagonist of certain receptors. It is characterized by its specific molecular structure, which contributes to its biological activity. The compound is often evaluated for its effects on various physiological processes, including its role in modulating neurotransmitter systems. In research contexts, SB 216641 has been investigated for its potential therapeutic effects, particularly in relation to neurological disorders. Its solubility, stability, and reactivity are important factors that influence its efficacy and safety profile in biological systems. As with many chemical substances, understanding its pharmacokinetics and pharmacodynamics is crucial for determining its potential applications in medicine. However, detailed information regarding its toxicity, side effects, and regulatory status may vary and should be consulted from specific scientific literature or databases for comprehensive insights.

SB 216641

170230-39-4: N-[3-[2-(Dimethylamino)ethoxy]-4-methoxyphenyl]-2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1′-biphenyl]-4-carboxamide, Sb 216641, [1,1'-Biphenyl]-4-carboxamide, N-[3-[2-(dimethylamino)ethoxy]-4-methoxyphenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-, hydrochloride (1:1), [1,1′-Biphenyl]-4-carboxamide, N-[3-[2-(dimethylamino)ethoxy]-4-methoxyphenyl]-2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)-

N-(3-(2-(Dimethylamino)ethoxy)-4-methoxyphenyl)-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxamide

SB 216641 is a 5-HT (1B/1D) antagonist with anxiolytic activity for the study of anxiety disorders and depression.

CAS 170230-39-4: SB 216641

SB 216641

Ref: 54-BUP01640

N-(3-(2-(Dimethylamino)ethoxy)-4-methoxyphenyl)-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxamide

Ref: IN-DA003U7E

SB 216641

Ref: TM-T85323